The global enzymes market size is estimated to be valued at USD 14.0 billion in 2024 and is projected to reach USD 20.4 billion by 2029, recording a CAGR of 7.8%. The biopharmaceutical industry's rapid growth, driven by advancements in biotechnology and personalized medicine, presents significant opportunities for the enzyme market. Enzymes are indispensable in biopharmaceutical manufacturing processes, including protein expression, purification, and modification. They are also used in the...